peptidefix

Peptides / 5-amino-1MQ / United States

5-amino-1MQ in the United States

Legal status, what it is, and the listed suppliers in the United States that list it.

Legal status in the United States

Not an approved medicine.

As understood at 2026-09-22. Verify with the FDA.

What 5-amino-1MQ is

5-amino-1MQ is not a peptide. It is a small molecule that inhibits nicotinamide N-methyltransferase, an enzyme that sits between cellular metabolism and the regulation of gene activity. It is a research compound with no published human data at all, and it is on this site because listed suppliers sell it alongside peptides.

Full 5-amino-1MQ page: targets and research →

Listed suppliers in the United States

5 of the 10 suppliers we list in the United States list 5-amino-1MQ. Listed, not endorsed: each row is the supplier’s own stated terms.

BioLongevity Labs United States All products are manufactured for research use only. Research Use Only products sold here are intended solely for laboratory research. HEEZ Research United States All products are for laboratory developmental research use only. Products are not for human consumption. HEEZ Research is a chemical supplier. Nationwide Peptides United States For Research Use Only. Products are not intended for human or animal consumption, ingestion, injection, or any form of administration. Peak Lab Peptides United States All products on this site are for research and development use only. Products are not for human consumption of any kind. Protide Health United States All products are supplied for laboratory research only and are not for human or animal consumption, medical use, veterinary use, or any therapeutic, diagnostic, or clinical purpose.

Clinical Research

Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction
Babula JJ, Bui D, Stevenson HL, et al. (2024). Diabetes, Obesity and Metabolism. animal diet-induced obese mice given the compound daily for 28 days, plus pharmacokinetic work after intravenous, oral and subcutaneous administration
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
Neelakantan H, Vance V, Wetzel MD, et al. (2018). Biochemical Pharmacology. animal cultured adipocytes and permeability assays, then mice made obese on a high-fat diet
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Kannt A, Rajagopal S, Kadnur SV, et al. (2018). Scientific Reports. animal diet-induced obese mice, ob/ob and db/db mice, and NNMT knockout mice as a specificity control
Exploring NNMT: from metabolic pathways to therapeutic targets
Park J, Shin EJ, Kim TH, et al. (2024). Archives of Pharmacal Research. review n/a (review)